Visit Abzena at booth #2711 at AAPS 2024 PharmaSci 360 taking place October 20-23, 2024, in Salt Lake City, Utah.

Schedule a meeting with our team of experts and let’s connect on your project-specific needs. We can also provide you with an update on our expanded global development and manufacturing capabilities.

• Dr Campbell Bunce, Chief Scientific Officer
• Parviz Ayai Shamlou, Sr. VP of Science & Technology
• Zoe Yi Zhang, VP of Business Development
• Julie Grace, VP of Business Development
• Yang Wang, Senior Director, Business Development

From antibodies (mAbs) to recombinant vaccines and bioconjugates including antibody-drug conjugates (ADCs), radioconjugates, and oligonucleotides, our team appreciates the chance to share how Abzena can assist in moving your program forward faster to its next milestone.

Don’t miss our two poster presentations…

Monday, October 21 at 3:30 PM – ‘Platform Approach for Identifying the Most Functional and Developable Bispecific T Cell Engager’

Wednesday, October 23 at 12:30 PM – ‘EpiScreen® 2.0 Time Course Assay: A Sensitive and Data Rich Tool for Pre-Clinical Immunogenicity Testing of Biologics’

We look forward to connecting with you at AAPS 2024 PharmaSci 360 in Salt Lake City, Utah.

Schedule a Meeting